Nurse-Administered Propofol Continuous Infusion Sedation for Gastrointestinal Endoscopy in Patients Who Are Difficult to Sedate

Hyun Seok Lee, Navroop Nagra, Danielle La Selva, Richard A. Kozarek, Andrew Ross, Wade Weigel, Ryan Beecher, Michael Chiorean, Michael Gluck, Elisa Boden, Nanda Venu, Rajesh Krishnamoorthi, Michael Larsen, Otto S. Lin

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Background & Aims: Patients who chronically use alcohol, marijuana, or opioids, or suffer from post-traumatic stress disorder (PTSD), can be difficult to sedate with midazolam and fentanyl, and often are referred for monitored anesthesia care during endoscopy. Nurse-administered propofol continuous infusion sedation (NAPCIS), which confers the benefit of propofol-based sedation without the added expense of anesthesia, is effective and safe for sedation of healthy patients. We investigated whether NAPCIS also is effective for patients who are difficult to sedate. Methods: We performed a retrospective study of patients who underwent upper endoscopy or colonoscopy with NAPCIS at a single center from January 2018 through April 2018. We reviewed records from patients who were heavy users of alcohol (n = 105), daily users of marijuana (n = 267) or opioids (n = 178), had a diagnosis of PTSD (n = 91), or were none of these (controls, n = 786). We compared mean fentanyl and propofol doses (adjusted for body weight), procedure and recovery times, procedure success rates, and adverse events. Results: Compared with the controls, the marijuana group required higher mean adjusted sedative doses for colonoscopies (0.6 vs 0.4 mcg/kg fentanyl and 5.0 vs 4.7 mg/kg propofol; P ≤. 025 for both) and upper endoscopies (0.8 vs 0.3 mcg/kg fentanyl and 3.7 vs 3.2 mg/kg propofol; P ≤. 021 for both), the PTSD group required a higher dose of fentanyl for colonoscopies (0.6 vs 0.4 mcg/kg; P = .009), and the alcohol group required a higher dose of fentanyl for upper endoscopies (0.7 vs 0.3 mcg/kg; P <. 001). Procedure success rates were high (95.1%–100%) and did not differ significantly between the difficult-to-sedate groups and controls; mean procedure times (7.0–9.0 minutes for upper endoscopies, 21.1–22.9 minutes for colonoscopies) and recovery times (22.5–29.6 minutes) also were similar among groups. Upper endoscopies were associated with lower sedative doses and shorter procedure and recovery times than colonoscopies. Sedation-related adverse events were rare in all groups (only 26 cases total), and there were no serious complications or deaths. Conclusions: NAPCIS seems to be a safe and effective means of providing sedation for endoscopy to patients who may be difficult to sedate owing to alcohol, marijuana, or opioid use, or PTSD.

Original languageEnglish (US)
Pages (from-to)180-188
Number of pages9
JournalClinical Gastroenterology and Hepatology
Volume19
Issue number1
DOIs
StatePublished - Jan 2021
Externally publishedYes

Keywords

  • Efficacy
  • Outcome
  • Risk Factor
  • Safety

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint

Dive into the research topics of 'Nurse-Administered Propofol Continuous Infusion Sedation for Gastrointestinal Endoscopy in Patients Who Are Difficult to Sedate'. Together they form a unique fingerprint.

Cite this